Adma Biologics (ADMA) Other Accumulated Expenses (2016 - 2026)
Adma Biologics (ADMA) posted Other Accumulated Expenses of $5.36 million for Q3 2026, up 109.1% from $2.56 million a year earlier and up 12.2% from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Other Accumulated Expenses (2016 - 2026) Analysis & Trends
At the end of FY2025, Adma Biologics' Other Accumulated Expenses came in at $4.17 million, up 108.8% from FY2024.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 82.3% (FY2020 to FY2025).
- In prior years, Adma Biologics' Other Accumulated Expenses was $2 million in FY2024 (-15.6%), $2.37 million in FY2023 (+31.7%), $1.8 million in FY2022 (+82.9%) and $981,721 in FY2021 (+373.7%).
- The Q3 2026 figure stands as the highest quarterly Other Accumulated Expenses since Q2 2025.
- On a year-over-year basis, Other Accumulated Expenses increased in four of the last eight quarters, with growth averaging 102.5%.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q2 2025, with growth of 663.1%; the weakest was Q2 2026, with a decline of 72.7%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $4.78 million (Q2 2026), $3.35 million (Q1 2026) and $4.17 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Adma Biologics | 2.87 Bn | 2.39 Bn | 99.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.36 Mn |
| Jun 30, 2026 | 4.78 Mn |
| Mar 31, 2026 | 3.35 Mn |
| Dec 31, 2025 | 4.17 Mn |
| Sep 30, 2025 | 2.56 Mn |
| Jun 30, 2025 | 17.49 Mn |
| Mar 31, 2025 | 2.05 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 3.32 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Mar 31, 2024 | 2.38 Mn |
| Dec 31, 2023 | 2.37 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 2.20 Mn |
| Mar 31, 2023 | 2.04 Mn |
| Dec 31, 2022 | 1.80 Mn |
| Sep 30, 2022 | 2.11 Mn |
| Jun 30, 2022 | 3.03 Mn |
| Mar 31, 2022 | 3.09 Mn |
| Dec 31, 2021 | 981,721.00 |
API Access
Adma Biologics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();